Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Corrigendum
Switching from a Non-Protease Inhibitor-Based Regimen to the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,897 | Dovepress* | 3,849+ | 71 | 3,920 | |
| PubMed Central* | 48 | 38 | 86 | ||
| Totals | 3,897 | 109 | 4,006 | ||
| *Since 27 October 2022 | |||||
View citations on PubMed Central and Google Scholar